Search company, investor...
RondinX company logo

The profile is currenly unclaimed by the seller. All information is provided by CB Insights.


Acquired | Acquired

About RondinX

RondinX is developing a drug discovery platform that develops solutions in the microbiome therapeutic and companion diagnostic spaces.

RondinX Headquarters Location

Tel Aviv,


Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Expert Collections containing RondinX

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

RondinX is included in 1 Expert Collection, including Omics.



275 items

Latest RondinX News

BiomX buys RondinX in Israeli microbiome merger | #VentureCanvas

Dec 26, 2017

Katie Roof | TechCrunch  Being the richest man in the world wasn’t enough. After Amazon shares climbed on Black Friday, founder and CEO Jeff Bezos saw his net worth rise to $100.3 billion, according to Bloomberg estimates. Amazon’s stock has […] Crypto

  • Where is RondinX's headquarters?

    RondinX's headquarters is located at Tel Aviv.

  • What is RondinX's latest funding round?

    RondinX's latest funding round is Acquired.

  • Who are the investors of RondinX?

    Investors of RondinX include BiomX.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.